As an intern at Beike Biotechnology I have been eager to see what opportunities and challenges are presented for an international company based in China, especially one in such a…
The Immunotherapy Revolution Is Under Way
New Wave Of Cancer Drugs 14 million new cancer cases a year 8.2 million cancer deaths in 2012. These shocking statistics show that cancer is a huge problem facing modern…
“e-Dura,” Another Spinal Cord Injury Breakthrough
2014 was undeniably a great year for spinal cord injury breakthroughs, and it seems 2015 is off to a strong start as well. These new SCI breakthroughs are truly ushering…
Overview A phase 2 study conducted, by Dr. Richard A. Nash, on 24 patients with relapsing-remitting MS showed extremely positive results, with 86% of patients relapse free for three years….
In Duchenne Muscular Dystrophy Stem Cells Found to be Faulty
Overview In a new study by Stanford University Medical Center mice with a form of Duchenne Muscular Dystrophy (DMD)underwent progressive muscle degeneration and accumulated connective tissue as they aged. Now,…
Source Concord Acquires Beike Biotechnology Shares
On the evening of December 22, the Source Concord Cell Gene Engineering Co., Ltd. (Source Concord) announced a 13 percent (118.7 million yuan) acquisition of shares held by Dr. Xiang…